Refine by
Parkinson S Disease Equipment & Supplies
58 equipment items found
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Squalamine inhibits tumor-related angiogenesis and the growth of human breast cancer cells. Squalamine restores the function of enteric nervous system in Parkinson,s disease mouse ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
We are developing mGlu4 PAM as a novel orally available treatment for Parkinson's disease. We are currently optimizing multiple chemical series of highly selective mGlu4 PAMs with compounds in early lead ...
Manufactured by:Valeo Pharma Inc. based inKirkland, QUEBEC (CANADA)
The first Parkinson’s Disease (PD) treatment in Canada since 2006, providing relief of symptoms during the off-phase in dopamine treated ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Parkinson’s disease is a neurodegenerative disorder that affects more than 6 million people worldwide. In most cases, the exact cause of Parkinson’s disease is unknown; however, mutations in GBA1, the gene that encodes the beta-glucocerebrosidase (GCase) enzyme, have been tied to the ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1601 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1602 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
Dipraglurant is a novel orally available highly selective metabotropic glutamate receptor subtype 5 negative allosteric modulator (mGlu5 NAM) which has completed Phase 1 and demonstrated efficacy in a Phase 2a proof of concept study for the treatment of levodopa-induced dyskinesia associated with Parkinson’s disease (PD-LID). This is a ...
Manufactured by:XPhyto Therapeutics Corporation based inVancouver, BRITISH COLUMBIA (CANADA)
Clinical studies are planned in 2021 to demonstrate the efficient transdermal delivery of a well-established Parkinson's disease ...
by:Pureims B.V. based inRoden, NETHERLANDS
Levodopa Cyclops™ is a levodopa dry powder inhaler for the fast and reliable relief of OFF episodes in Parkinson’s disease. As such, Levodopa Cyclops™ answers a major unmet medical need. Levodopa is the cornerstone in the treatment of Parkinson’s disease for well over 50 ...
Manufactured by:Trailhead Biosystems Inc. based inBeachwood, OHIO (USA)
We have developed a novel three-stage protocol that uses only small molecules to make human dopaminergic neurons of the midbrain from induced pluripotent stem cells ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The drug candidate ABBV-0805 is a monoclonal antibody that selectively binds and eliminates oligomers and protofibrils of alpha-synuclein. The goal is to develop a disease modifying treatment that stops or slows down disease ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
mGlu2 NAM for the treatment of mild neurocognitive disorders, or mNCD. We are developing mGlu2 NAM as a novel orally available treatment for mNCD associated with Alzheimer’s disease, Parkinson’s disease and depressive disorders. The program is in clinical candidate selection phase and we expect to ...
Manufactured by:ACP - Accelerated Care Plus Corporation based inReno, NEVADA (USA)
The next step in balance training, the OmniStand® dynamic balance system gives therapists the freedom to work with individual patients to provide effective, progressive balance and gait-training. This fall-safe system provides adjustable, dynamic sway to challenge patients while keeping them safely supported. Therapists can unlock a patient’s potential within their cone of stability and ...
Manufactured by:Dobons Technology S.L. based inSanta Cruz de Tenerife, SPAIN
The laboratory for Electromedical Applications designs and builds at present a sort of instruments and systems derived from a 20 year old actitivity in the fields of ophtalmology (automated perimetry), physiology and, more recently, neurosurgery. ...
Manufactured by:Great Lakes NeuroTechnologies based inCleveland, OHIO (USA)
The KinesiaU™ motor assessment system serves as a clinically validated, cost-effective prescription application designed for individuals managing Parkinson’s disease and essential tremor. This innovative system is compatible with both iPhone and Android smartphones, as well as smartwatches, allowing users to systematically track core symptoms including tremors, slowness, and dyskinesia. ...
Manufactured by:LTS Lohmann Therapie-Systeme AG based inAndernach, GERMANY
LTS Lohmann Therapie-Systeme AG specializes in transdermal therapeutic systems (TTS) that enhance patient outcomes by ensuring controlled and balanced drug release, reducing peak concentrations, and mitigating common side effects such as nausea and vomiting. These systems provide a non-invasive delivery route, suitable for active substances with low oral bioavailability, ensuring improved ...
Manufactured by:Aviva Systems Biology Corporation based inSan Diego, CALIFORNIA (USA)
25 ugof the indicated Human whole cell extracts was loaded onto a 12%SDS-PAGEgel. 3 ug/mL of the antibody was used in this ...
Manufactured by:Alkahest, Inc. based inSan Carlos, CALIFORNIA (USA)
Alkahest, with its partner Grifols, is developing lead clinical candidates, GRF6019 and GRF6021, as potential treatments for neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease with cognitive impairment. Designed to safely replenish regenerative positive ...
Manufactured by:AnaSpec based inFremont, CALIFORNIA (USA)
Parkinson's disease is predominantly a movement disorder resulting from degeneration of dopaminergic neurons in the substantia nigra. The cause of the disease is unknown, but substantial evidence suggests that the aggregation of α-synuclein is a critical step in the etiology of Parkinson's disease (PD). α-Synuclein is an abundant brain protein of 140 residues that is present in high ...
Manufactured by:Kaneka Eurogentec S.A. based inSeraing, BELGIUM
α-Synuclein is a major component of Lewy bodies in the affected neurons in Parkinson's disease. This protein has a mass of 14.5 kDa (140 amino acids long) and consists of a conserved degenerative amino-terminal domain and an acidic carboxyl-terminal with higher sequence divergence. α-Synuclein is predominantly expressed in brain, specifically in cerebellum, thalamus, neocortex, ...